These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35214649)

  • 1. Head-to-Head Comparison of Response Rates to the Two mRNA SARS-CοV-2 Vaccines in a Large Cohort of Solid Organ Transplant (SOT) Recipients.
    Marinaki S; Degiannis D; Roussos S; Xagas E; Tsoutsoura P; Adamopoulos S; Sypsa V; Chaidaroglou A; Pavlopoulou ID; Hatzakis A; Boletis IN
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.
    Tsoutsoura P; Xagas E; Roussos S; Hatzakis A; Gourzi P; Boletis IN; Marinaki S
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374279
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective study.
    Yoshikawa M; Natori Y; Oki R; Unagami K; Ohfuji S; Imamura R; Ishida H; Takahara S; Hirota Y; Egawa H
    Scand J Immunol; 2023 Oct; 98(4):e13308. PubMed ID: 38441221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
    Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
    JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
    Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
    Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
    Giannella M; Pierrotti LC; Helanterä I; Manuel O
    Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses.
    Grupper A; Katchman H
    Curr Transplant Rep; 2022; 9(1):35-47. PubMed ID: 35096509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and solid organ transplantation: Finding the right balance.
    Opsomer R; Kuypers D
    Transplant Rev (Orlando); 2022 Jul; 36(3):100710. PubMed ID: 35809422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.
    Chen X; Luo D; Mei B; Du J; Liu X; Xie H; Liu L; Su S; Mai G
    Clin Microbiol Infect; 2023 Apr; 29(4):441-456. PubMed ID: 36509376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
    Sandoval M; Nguyen DT; Huang HJ; Yi SG; Ghobrial RM; Gaber AO; Graviss EA
    PLoS One; 2022; 17(12):e0279222. PubMed ID: 36542654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
    Kabbani D; Yotis DM; Ferreira VH; Shalhoub S; Belga S; Tyagi V; Ierullo M; Kulasingam V; Hébert MJ; West L; Delisle JS; Racine N; De Serres SA; Cardinal H; Dieudé M; Humar A; Kumar D
    Open Forum Infect Dis; 2023 May; 10(5):ofad200. PubMed ID: 37213422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients.
    Zingaropoli MA; Guardiani M; Dominelli F; Tortellini E; Garofalo M; Cogliati Dezza F; Centofanti A; Carillo C; Napoli A; Venuta F; Mastroianni CM; Pretagostini R; Lichtner M; Ciardi MR; Russo G
    Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine.
    Abravanel F; Marion O; Del Bello A; Beunon T; Romieu-Mourez R; Couat C; Pucelle M; Staes L; Guitard J; Esposito L; Faguer S; Kamar N; Izopet J
    Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients.
    Peghin M; Graziano E; Grossi PA
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.
    Alotaibi AS; Shalabi HA; Alhifany AA; Alotaibi NE; Alnuhait MA; Altheaby AR; Alhazmi AY
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant.
    Cassaniti I; Bergami F; Arena F; Sammartino JC; Ferrari A; Zavaglio F; Curti I; Percivalle E; Meloni F; Pandolfi L; Pellegrini C; Turco A; Seminari E; Pattonieri EF; Gregorini M; Rampino T; Sarasini A; Lilleri D; Baldanti F
    Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.
    Meshram HS; Kute V; Rane H; Dave R; Banerjee S; Mishra V; Chauhan S
    Transpl Infect Dis; 2022 Dec; 24(6):e13926. PubMed ID: 35924679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.